Stop-smoking program using nicotine reduction therapy and behavior modification for heavy smokers.
One hundred eighteen volunteers were studied in a hospital-based smoking cessation program in which nicotine polacrilex (Nicorette) was used as an adjunct to behavioral modification (group support). The "success" rate of 40% to 47% at 1 year was chemically verified. The regimen for using the nicotine polacrilex was "within labeling" but decidedly different from the regimen used in most smoking cessation programs involving this product.
Cooper
T M
TM
Department of Oral Health Sciences, College of Dentistry, University of Kentucky, Lexington.
Clayton
R R
RR
D000328:Adult; D000368:Aged; D001521:Behavior Therapy; D002638:Chewing Gum; D005260:Female; D006801:Humans; D007508:Irritable Mood / Q000187:drug effects; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009538:Nicotine / Q000009:adverse effects* / Q000031:analogs & derivatives*; D011109:Polymethacrylic Acids; D011145:Polyvinyls; D011446:Prospective Studies; D011897:Random Allocation; D012907:Smoking / Q000628:therapy*; D013375:Substance Withdrawal Syndrome; D061485:Tobacco Use Cessation Devices
D002638:Chewing Gum; D011109:Polymethacrylic Acids; D011145:Polyvinyls; D009538:Nicotine